Cargando…
Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population
OBJECTIVES: To understand the discrepancy between the published 10-year cardiovascular risk and 10-year cardiovascular risk generated from raw data using the Framingham Risk Score for participants in the Systolic Blood Pressure Intervention Trial (SPRINT). DESIGN: Secondary analysis of SPRINT data p...
Autores principales: | Warner, Frederick, Dhruva, Sanket S, Ross, Joseph S, Dey, Pranammya, Murugiah, Karthik, Krumholz, Harlan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059296/ https://www.ncbi.nlm.nih.gov/pubmed/30037874 http://dx.doi.org/10.1136/bmjopen-2018-021685 |
Ejemplares similares
-
Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
por: Huang, Chenxi, et al.
Publicado: (2017) -
Blood pressure lowering treatment and the Framingham score: Do not fear risk
por: Brouwer, Tom F., et al.
Publicado: (2019) -
Assessment of cardiovascular risk in Tunisia: applying the Framingham risk score to national survey data
por: Saidi, O, et al.
Publicado: (2016) -
Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis
por: Jin, Hao, et al.
Publicado: (2023) -
Application of the modified Framingham cardiovascular risk score to newly diagnosed type 2 black African diabetic patients
por: Kengne, Andre Pascal, et al.
Publicado: (2007)